Leader, Applied Science & Technology
Doane leads the Applied Science and Technology organization for Corteva Agriscience™. In this role, Doane leads a group of scientists whose responsibilities include high throughput vector construction, protein engineering (gene shuffling, phage display), genome engineering (CRISPR-Cas9), plant transformation, genomics (Illumina, PacBio, Bionano, Oxford, high throughput qPCR), greenhouses/controlled environments, metabolomics (GC/MS), protein production, protein quantification, analytic chemistry, and spectroscopy (single seed, field, greenhouse). AST supports the entire Corteva R&D portfolio, with a primary focus on the seed business. AST includes more than 250 researchers.
AST is a world leader in plant transformation, genome editing and genomics technologies. Examples include development of highly efficient genotype independent site-specific marker free maize transformation, the discovery of novel DSB reagents including Cas 12f, development of novel Cas9 off-site detection methods, and development of methods for high volume production of de novo gapless reference genomes.
Prior to joining Corteva (then Pioneer Hi-Bred) in 2011, Doane was CEO and cofounder Cobax Biopharma, an anti-infective biotech focused on development of human bacteriotherapies. Before that he was Senior Director of Commercial Strategy at Replidyne, a public biotechnology company focused on the development of novel small molecule antibiotics. Doane was previously an associate partner with McKinsey and Company in Chicago and Los Angeles, with a practice that focused on life science companies: agriculture, biochemical reagents, and pharma/biotech. Doane is Chief Technology Officer for the State of Iowa and Chair of Genome Canada’s Science and Industry Advisory Board.
Doane received his B.A. in Biology from Grinnell College and his Ph.D. in Molecular Genetics and Cell Biology from the University of Chicago.